A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...

Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...

The company announced that the US FDA has expanded the approved use of its oral antiviral drug Mavyret, developed in ...

The solution automatically labels subdural collections and reports measurements such as thickness, midline shift, and volume.

This story is from the next print edition of MIT Technology Review, which explores power—who has it, and who wants it. It’s ...

Insmed Incorporated (NASDAQ:INSM) is a New Jersey-based biopharmaceutical company that develops and markets therapies to ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including advances in sleep apnea ...

Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for the relief of moderate to severe nasal ...

About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases, to epidemic and even pandemic outbreaks, as we experienced with the COVID ...

Simulations Plus faces weak biopharma demand, slowing growth, margin pressure, and high valuation amid M&A reliance. See why ...